imipramine hydrochloride- imipramine hydrochloride tablet, film coated
remedyrepack inc. - imipramine hydrochloride (unii: bke5q1j60u) (imipramine - unii:ogg85sx4e4) - for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than other depressive states. one to three weeks of treatment may be needed before optimal therapeutic effects are evident. may be useful as temporary adjunctive therapy in reducing enuresis in children aged 6 years and older, after possible organic causes have been excluded by appropriate tests. in patients having daytime symptoms of frequency and urgency, examination should include voiding cystourethrography and cystoscopy, as necessary. the effectiveness of treatment may decrease with continued drug administration. the concomitant use of monoamine oxidase inhibiting compounds is contraindicated. hyperpyretic crises or severe convulsive seizures may occur in patients receiving such combinations. the potentiation of adverse effects can be serious, or even fatal. when it is desired to substitute imipramine hydrochloride tablets usp in patients receiving a monoamine oxidase inhibitor, as long an interval should elap
trimipramine 10mg tablets
kent pharma (uk) ltd - trimipramine maleate - oral tablet - 10mg
trimipramine 10mg tablets
a a h pharmaceuticals ltd - trimipramine maleate - oral tablet - 10mg
trimipramine 10mg tablets
alliance healthcare (distribution) ltd - trimipramine maleate - oral tablet - 10mg
trimipramine 10mg tablets
sigma pharmaceuticals plc - trimipramine maleate - oral tablet - 10mg
trimipramine 10mg tablets
phoenix healthcare distribution ltd - trimipramine maleate - oral tablet - 10mg
trimipramine 10mg tablets
waymade healthcare plc - trimipramine maleate - oral tablet - 10mg
trimipramine 10mg tablets
pilsco ltd - trimipramine maleate - oral tablet - 10mg
trimipramine 10mg tablets
cst pharma ltd - trimipramine maleate - oral tablet - 10mg
trimipramine 10mg tablets
de pharmaceuticals - trimipramine maleate - oral tablet - 10mg